American Cancer Society. Breast Density and your Mammogram Report. 2025.
Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), Deutsche Krebsgesellschaft (DKG). S3-Leitlinie Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms. AWMF register no.: 032-045OL. 2025.
Henderson JT, Webber EM, Weyrich MS et al. Screening for Breast Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2024; 331(22): 1931-1146.
Huo CW, Chew GL, Britt KL et al. Mammographic density-a review on the current understanding of its association with breast cancer. Breast Cancer Res Treat 2014; 144(3): 479-502.
Hussein H, Abbas E, Keshavarzi S et al. Supplemental Breast Cancer Screening in Women with Dense Breasts and Negative Mammography: A Systematic Review and Meta-Analysis. Radiology 2023; 306(3): e221785.
Lester SP, Kaur AS, Vegunta S. Association Between Lifestyle Changes, Mammographic Breast Density, and Breast Cancer. Oncologist 2022; 27(7): 548-554.
Melnikow J, Fenton JJ, Whitlock EP et al. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force. Ann Intern Med 2016; 164(4): 268-278.
Nelson HD, Zakher B, Cantor A et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med 2012; 156(9): 635-648.
Ontario Health (Quality). Supplemental Screening as an Adjunct to Mammography for Breast Cancer Screening in People With Dense Breasts: A Health Technology Assessment. Ont Health Technol Assess Ser 2023; 23(9): 1-293.
Weigel S, Heindel W, Heidrich J et al. Digital mammography screening: sensitivity of the programme dependent on breast density. Eur Radiol 2017; 27(7): 2744-2751.
Yuan WH, Hsu HC, Chen YY et al. Supplemental breast cancer-screening ultrasonography in women with dense breasts: a systematic review and meta-analysis. Br J Cancer 2020; 123(4): 673-688.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.